| |
|
|
|
Caladrius Bio  
|
|
2.225 -0.165 (-0.07%) |
01-25 12:26 |
|
Open: |
2.35 |
Pre close: |
2.39 |
Target:
|
4.14
|
|
High: |
2.41 |
Low: |
2.15 |
Resistance:
|
3.55
4.89
|
|
Volume: |
2,001,777 |
Market Cap: |
43M |
Support:
|
1.37
1.14
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.33
 |
MACD |
MACD(12,26):
|
0.21 |
|
MA(20): |
1.73 |
Signal(12,26,9): |
0.11 |
|
MA(100): |
1.67 |
Stochastic Oscillator |
%K(14,3):
|
28.50  |
|
MA(250): |
1.97 |
%D(3): |
39.41 |
|
Average Volume(K) |
3-Month: |
258467
|
52-Week |
High:
|
4.89 |
|
10-Days: |
1445249 |
Low: |
1.05 |
|
RSI |
RSI(14):
|
61.92 |
Change(%): |
-25.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.581 |
Return on Equity (ttm) |
-24.5 |
Shares Out. (M) |
19.40 |
|
EPS Est. Current Year |
-2.420 |
Return on Assets (ttm) |
-31.9 |
Shares Float (M) |
16.01 |
|
EPS Est. Next Year |
-2.950 |
PEG Ratio |
0.00 |
% Held by Insiders |
12.18 |
|
EPS Est. Next Quarter |
-0.770 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
19.23 |
|
Forward EPS |
-1.880 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
130 |
|
Book Value (p.s.) |
1.950 |
EBITDA (p.s.) |
-0.965 |
P/E |
-3.84 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.14 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-7.48 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-12.36 |
P/CF |
-5.78 |
|
|
|
|
|
|
